| Ytd | 10.40% | |
| 1y | 154.10% |
| Open | 167.57 | Prev Close | 167.26 | Low | 167.00 | High | 179.04 | Mkt Cap | 7.08B |
| Vol | 173.79K | Avg Vol | 206.12K | EPS | -1.87 | P/E | -94.44 | Forward P/E | 172.15 |
| Beta | -1.22 | Short Ratio | 5.96 | Inst. Own | 23.37% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 149.96 | 200-d Avg | 152.27 | 1yr Est | 210.50 |
BLTE News
SAN DIEGO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “C
Belite Bio (BLTE) is positioned for upside with tinlarebant, an oral therapy for Stargardt disease,
Panelists at the H.C. Wainwright Sixth Annual Ophthalmology Virtual Conference said investigational
Tinlarebant is the first therapeutic candidate to demonstrate clinical efficacy in Stargardt disease
SAN DIEGO, July 15, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “C
Belite Bio NASDAQ: BLTE Chief Medical Officer Hendrik Scholl said the company is advancing its lead
SAN DIEGO, July 06, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “C
SAN DIEGO, July 06, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “C
SAN DIEGO, June 12, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) ("Belite Bio" or the "Co
Belite Bio, Inc (BLTE) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Trans
SAN DIEGO, June 02, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “C
Belite Bio, Inc (BLTE) Q1 2026 Earnings Call Transcript
Belite Bio NASDAQ: BLTE said it has begun a rolling New Drug Application submission to the U.S. Food
SAN DIEGO, May 20, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Co
SAN DIEGO, May 18, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Co
SAN DIEGO, May 15, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), (“Belite Bio®” or the “
Belite Bio, Inc (BLTE) Presents at Bank of America Global Healthcare Conference 2026 Transcript
SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), (“Belite Bio®” or the “
Belite Bio, Inc (BLTE) Presents at Deutsche Bank ADR Virtual Investor Conference Transcript
Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $
Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earni
Gainers Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) shares jumped 143% to $0.45 after the company
Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is estimated to report earnings for i
Gainers Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) gained 126.5% to settle at $2.65 on Tu
Gainers Revlon, Inc. (NYSE: REV) rose 125.5% to $2.6499. Revlon’s stock dropped sharply on Monday
Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares surged 126% to close at $14.96 on
Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares jumped 110% to $13.93 after the com